10q10k10q10k.net
electroCore, Inc.

electroCore, Inc.ECOREarnings & Financial Report

Nasdaq

electroCore, Inc. is a medical technology company based in Basking Ridge, New Jersey. electroCore was co-founded in 2005 by JP Errico, Thomas J. Errico, MD, Charles Theofilos, MD, and Peter Staats, MD. The current chief executive officer is Daniel S. Goldberger. electroCore has one product called gammaCore, a non-invasive, commercially available product that uses vagus nerve stimulation.

NextMar 25, 2026

ECOR Q3 2025 Key Financial Metrics

Revenue

$8.7M

Gross Profit

$7.5M

Operating Profit

$-2.9M

Net Profit

$-3.4M

Gross Margin

86.0%

Operating Margin

-33.2%

Net Margin

-39.2%

YoY Growth

32.6%

EPS

$-0.40

Financial Flow

electroCore, Inc. Q3 2025 Financial Summary

electroCore, Inc. reported revenue of $8.7M for Q3 2025, with a net profit of $-3.4M (-39.2% margin). Cost of goods sold was $1.2M, operating expenses totaled $10.4M.

Key Financial Metrics

Total Revenue$8.7M
Net Profit$-3.4M
Gross Margin86.0%
Operating Margin-33.2%
Report PeriodQ3 2025

electroCore, Inc. Annual Revenue by Year

electroCore, Inc. annual revenue history includes year-by-year totals (for example, 2024 revenue was $25.2M).

YearAnnual Revenue
2024$25.2M
2023$16.0M
2022$8.6M

Income Statement

Q4 2023Q1 2024Q2 2024Q3 2024Q4 2024Q1 2025Q2 2025Q3 2025
Revenue$5.2M$5.4M$6.1M$6.6M$7.0M$6.7M$7.4M$8.7M
YoY Growth102.8%95.8%72.9%45.4%35.7%23.4%20.2%32.6%

Balance Sheet

Q4 2023Q1 2024Q2 2024Q3 2024Q4 2024Q1 2025Q2 2025Q3 2025
Assets$16.1M$13.9M$22.4M$21.0M$20.5M$16.0M$14.6M$21.4M
Liabilities$8.7M$9.4M$10.9M$11.6M$12.9M$11.7M$13.4M$22.5M
Equity$7.4M$4.5M$11.5M$9.5M$7.5M$4.4M$1.1M$-1.1M

Cash Flow

Q4 2023Q1 2024Q2 2024Q3 2024Q4 2024Q1 2025Q2 2025Q3 2025
Operating CF$-3.1M$-2.6M$-1.8M$-1.4M$-1.3M$-4.4M$-623000$-1.7M